ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Cognitive assessment of patients with post-COVID olfactory dysfunction and impaired domains.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPersistent olfactory dysfunction is a common symptom of post-COVID syndrome (PCS), particularly among younger patients who experienced mild COVID-19. Recent functional neuroimaging studies suggest that persistent olfactory impairment may be associated with cognitive deficits. However, few studies have characterised cognition in this subgroup using standardised neuropsychological assessment.
objectivesTo assess the prevalence of cognitive deficits and their characteristics in patients with persistent post-COVID olfactory symptoms.
methodsThis multicentre study included 55 patients with PCS and persistent olfactory dysfunction following COVID-19 onset before February 2021. Participants underwent olfactory evaluation using the Sniffin' Sticks test and a comprehensive battery of neuropsychological assessments.
resultsThe mean age was 43.9 years (SD 10.1), with a mean disease duration of 46.1 months (SD 6.5). According to a domain-based criterion, 67.3% of patients showed cognitive impairment. Domain-specific impairment was observed in attention/working memory (67.3%), executive function (50.9%), and episodic memory (56.4%). The Montreal Cognitive Assessment (MoCA) detected abnormalities in only 9.1% of patients. Exploratory comparisons between hyposmic and anosmic patients showed no univariate differences after false discovery rate (FDR) correction, despite a marginal post-hoc multivariate effect. Continuous olfactory performance showed inverse correlations with two executive measures after FDR correction, but no consistent dose-response relationship across cognitive measures.
conclusionIn this selected cohort, a high prevalence of multidomain cognitive alterations was observed. These findings highlight the limitations of brief cognitive screening tools and suggest a complex relationship between persistent olfactory dysfunction and cognition. Further longitudinal studies are warranted.
Indexed as
Identifiers
42870121What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.